IMRX
Immuneering Corporation Class A Common Stock
stockNASDAQ
At CloseNov 13, 2026 3:59:59 PM EST
3.71USD+1.090%(+0.04)847,339
Pre-marketNov 13, 2026 9:28:30 AM EST
3.73USD+1.635%(+0.06)
After-hoursNov 13, 2026 4:00:30 PM EST
3.71USD0.000%(-0.00)
IMRX Financials
In Q3 FY 2026 (ended ), Immuneering Corporation Class A Common Stock (IMRX) reported net income of −$24.19M, operating cash flow of −$16.79M, and assets of $182.56M (filed ).
Loading financial flows…